Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Frontiers in Oncology|June 26, 2020
Dysregulated m6A-Related Regulators Are Associated With Tumor Metastasis and Poor Prognosis in OsteosarcomaJianhao Li, Benchen Rao, Jie Yang, et al.
Virulence|February 7, 2024
Safety and immunogenicity of CoronaVac in healthy adults: A prospective observational multicenter real-world study in Henan Province, ChinaBenchen Rao, Ling Wang, Mengzhao Yang, et al.
Scientific Reports|October 14, 2025
Dynamic alterations of oral fungal microbiota in Omicron infected patientsYarong Ma, Shanshuo Liu, Guizhen Zhang, et al.
Frontiers in Microbiology|February 13, 2026
Camptothecin-PHA nanoparticles attenuate drug-induced gut microbiome dysbiosis and metabolic toxicityShanshuo Liu, Benchen Rao, Wenjie Liu, et al.
Frontiers in Cellular and Infection Microbiology|August 28, 2020
Fecal Microbiomes Distinguish Patients With Autoimmune Hepatitis From Healthy IndividualsJiamin Lou, Yan Jiang, Benchen Rao, et al.
BMC Oral Health|February 23, 2026
Alterations of the oral mycobiome in patients with CCATong Ren, Bohan Jia, Benchen Rao, et al.
Frontiers in Microbiology|January 24, 2022
Gut Microbiome Distinguishes Patients With Epilepsy From Healthy IndividualsGuangying Cui, Shanshuo Liu, Zhenguo Liu, et al.
Cell Death & Disease|October 10, 2020
SPATS2, negatively regulated by miR-145-5p, promotes hepatocellular carcinoma progression through regulating cell cycleGang Dong, Shanshan Zhang, Shen Shen, et al.
Frontiers in Cellular and Infection Microbiology|June 7, 2021
Oral Microbiome Characteristics in Patients With Autoimmune HepatitisBenchen Rao, Jiamin Lou, Haifeng Lu, et al.
BMC Infectious Diseases|February 25, 2025
Real-world effectiveness and safety of oral Azvudine versus Paxlovid for COVID-19 in patients with kidney disease: a multicenter, retrospective, cohort studyBenchen Rao, Daming Wang, Mengzhao Yang, et al.
Pageof 3